FACS as a Screening Method for Directed Evolution of GTs
A R T I C L E S
thereby improving the chances of identifying useful mutations.10,11
The development of high-throughput, low-cost screens for the
interrogation of large GT libraries is therefore of great interest.
Fluorescence-activated cell sorting (FACS) is a specialized
application of flow cytometry.12,13 In a FACS instrument,
multiple fluorescent parameters (size, structure, and fluorescent
signals) of individual sample particles (cells, microbeads, or
emulsions) can be analyzed by a focused laser beam at rates of
approximately 107/h. A charge can be applied to the particles
of interest, which are deflected into a collection tube by a
charged plate. Originally developed for the analysis of
protein-ligand interactions, FACS has recently emerged as a
powerful tool for screening enzyme libraries due to its unique
sensitivityanditsabilitytoanalyzeasmanyas108 mutants/day.14-16
The major challenge in FACS screening is how to maintain the
link between genotype and phenotype because most enzyme
substrates do not remain associated with the cells. Several
different FACS screening approaches have been developed,
largely based on the attachment of products to cell surfaces or
entrapment of the product inside the cells, and these have been
applied to the directed evolution of proteases,17-20 peroxidases,21
esterases,22 glutathione transferases,23-25 and nucleoside ki-
nases26 in order to improve their expression level, stability,
ligand binding, activity, or substrate specificity. We have
recently reported a novel FACS-based, high-throughput screen-
ing method, which makes use of differences in physical
properties between the substrate and product, for the directed
evolution of the sialytransferase CstII from Campylobacter
jejuni.27 Libraries of mutant sialyltransferase (ST) genes were
expressed in Escherichia coli cells that are naturally permeable
to an exogenous glycosyl acceptor (Bodipy-lactose, 1) (Figure
1). Active STs catalyzed sialylation of 1, entrapping the charged
fluorescent product within the cell and thereby co-localizing the
Figure 1. Fluorescently labeled lactose (1) and differentially labeled
N-acetyl-D-galactosamine (2 and 3) derivatives used in screens for glyco-
syltransferase activity.
genotype and phenotype (Figure 2a). Using FACS, the library
was screened at a rate of more than 107 events/h and an ST
variant with up to 400-fold improved activity for 1 was thus
identified. However, improvements were specific to 1, as
enhanced activity had arisen from the evolution of a binding
site for the substrate-appended fluorophore, as demonstrated
crystallographically.27 An approach that avoids the coincident
evolution of dye binding sites is therefore necessary.
Here, we present a method to evolve improved GT activity
through simultaneous use of two selection substrates bearing
the same sugar but chemically distinct fluorophores, thereby
minimizing the probability of selecting for a dye-binding site
(Figure 2b). Significantly, we have applied this strategy to a
ꢀ-1,3-galactosyltransferase (CgtB), which transfers the neutral
sugar galactose, thereby demonstrating that cellular entrapment
is not restricted to charged products and highlighting the
generality of this ultra-high-throughput screen for GTs. Screen-
ing of a library of >107 CgtB mutants against fluorescently
labeled derivatives of N-acetylgalactosamine (2 and 3) identified
a range of improved mutants, with up to 300-fold enhanced
catalytic activities and improved ability to synthesize GM1a and
asialo GM1 oligosaccharides, the building blocks of important
therapeutic glycosphingolipids.
(10) Aharoni, A.; Amitai, G.; Bernath, K.; Magdassi, S.; Tawfik, D. S.
Chem. Biol. 2005, 12, 1281–1289.
(11) Dietrich, J. A.; McKee, A. E.; Keasling, J. D. Annu. ReV. Biochem.
2010, 79, 563–590.
(12) Givan, A. L. Flow Cytometry: First Principles; Wiley-Liss: NY, 1992.
(13) Shapiro, H. M. Practical Flow Cytometry, 4th ed.; Wiley-Liss: NY,
2004.
(14) Becker, S.; Schmoldt, H. U.; Adams, T. M.; Wilhelm, S.; Kolmar, H.
Curr. Opin. Biotechnol. 2004, 15, 323–329.
(15) Farinas, E. T. Comb. Chem. High Throughput Screening 2006, 9, 321–
328.
Experimental Section
(16) Yang, G.; Withers, S. G. ChemBioChem 2009, 10, 2704–2715.
(17) Olsen, M. J.; Stephens, D.; Griffiths, D.; Daugherty, P.; Georgiou,
G.; Iverson, B. L. Nat. Biotechnol. 2000, 18, 1071–1074.
(18) Varadarajan, N.; Gam, J.; Olsen, M. J.; Georgiou, G.; Iverson, B. L.
Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 6855–6860.
(19) Varadarajan, N.; Rodriguez, S.; Hwang, B. Y.; Georgiou, G.; Iverson,
B. L. Nat. Chem. Biol. 2008, 4, 290–294.
Generation of Random-Mutagenesis Library. DNA encoding
amino acids 1-272 of CgtB was subjected to error-prone PCR using
the Gene Morph II Mutagenesis kit (Stratagene) with 0.03 ng or
0.06 ng of pCW-CgtB∆C30-MalE as template, following the
manufacturer’s protocol. The primers used were CgtB-F, 5′-GAA-
AGGGAGCTCACATATGTTTAAAATTTCAATCATCTTACC-
AAC-3′ and CgtB-R, 5′-GAAGGTCGGAATTCCGGTTTTATTT-
TATATATTTGAATATATAGC-3′. The PCR product was di-
gested and ligated to pCW-MalE-C vector using NdeI and EcoRI
restriction sites and the ligation mixture was electroporated to E.
cloni 10G elite cells (Lucigen) according to the manufacturer’s
protocol. The transformed cells were grown overnight at 37 °C in
LB medium supplemented with ampicillin (100 mg/mL) and the
library plasmid DNA was extracted. Several individual clones
from each library were sequenced and shown to have an average
mutational frequency of ∼2 and ∼5 mutations per gene in the
0.03 and 0.06 ng template libraries, respectively. The plasmid
DNA from the two libraries was mixed in a 1:1 ratio and was
transformed into E. coli JM107* for screening.28 These were the
(20) Varadarajan, N.; Georgiou, G.; Iverson, B. L. Angew. Chem., Int. Ed.
2008, 47, 7861–7863.
(21) Lipovsek, D.; Antipov, E.; Armstrong, K. A.; Olsen, M. J.; Klibanov,
A. M.; Tidor, B.; Wittrup, K. D. Chem. Biol. 2007, 14, 1176–1185.
(22) Becker, S.; Ho¨benreich, H.; Vogel, A.; Knorr, J.; Wilhelm, S.; Rosenau,
F.; Jaeger, K. E.; Reetz, M. T.; Kolmar, H. Angew. Chem., Int. Ed.
2008, 47, 5085–5088.
(23) Kawarasaki, Y.; Griswold, K. E.; Stevenson, J. D.; Selzer, T.;
Benkovic, S. J.; Iverson, B. L.; Georgiou, G. Nucleic. Acids. Res. 2003,
31, e126.
(24) Griswold, K. E.; Kawarasaki, Y.; Ghoneim, N.; Benkovic, S. J.;
Iverson, B. L.; Georgiou, G. Proc. Natl. Acad. Sci. U.S.A. 2005, 102,
10082–10087.
(25) Griswold, K. E.; Aiyappan, N. S.; Iverson, B. L.; Georgiou, G. J.
Mol. Biol. 2006, 364, 400–410.
(26) Liu, L.; Li, Y.; Liotta, D.; Lutz, S. Nucleic Acids Res. 2009, 37, 4472–
4481.
(27) Aharoni, A.; Thieme, K.; Chiu, C. P.; Buchini, S.; Lairson, L. L.;
Chen, H.; Strynadka, N. C.; Wakarchuk, W. W.; Withers, S. G. Nat.
Methods. 2006, 3, 609–614.
(28) Antoine, T.; Heyraud, A.; Bosso, C.; Samain, E. Angew. Chem., Int.
Ed. 2005, 44, 1350–1352.
9
J. AM. CHEM. SOC. VOL. 132, NO. 30, 2010 10571